Literature DB >> 7339376

[Controversial viewpoints on the use of historical controls: Is there an all-or-nothing law?].

G Feifel.   

Abstract

In the field of clinical trials the choice of appropriate controls has often given rise to controversy. Historical controls rely too often on biased, incomplete, and inappropriate information. Historical controls may be suitable if the natural history of the illness is known and stable or for planning prospective studies. The minimal requirement for use of historical controls is to explain the methods by which the data were collected. When the goal of clinical investigation is to test for a true difference, a randomized clinical study should be performed.

Mesh:

Year:  1981        PMID: 7339376     DOI: 10.1007/bf01286878

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  25 in total

1.  Sounding board. Are randomized trials appropriate for evaluating new operations?

Authors:  L I Bonchek
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

2.  Non-randomized controls in cancer clinical trials.

Authors:  E A Gehan; E J Freireich
Journal:  N Engl J Med       Date:  1974-01-24       Impact factor: 91.245

3.  Fluorouracil as an adjuvant to surgery in carcinoma of the colon.

Authors:  G A Higgins; R W Dwight; J V Smith; R J Keehn
Journal:  Arch Surg       Date:  1971-04

4.  Amputation and adriamycin in primary osteosarcoma.

Authors:  E P Cortes; J F Holland; J J Wang; L F Sinks; J Blom; H Senn; A Bank; O Glidewell
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

5.  A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction.

Authors:  R H Gifford; A R Feinstein
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

6.  Improved survival after coronary artery surgery in patients with extensive coronary artery disease.

Authors:  D J Ullyot; J Wisneski; R W Sullivan; E W Gertz
Journal:  J Thorac Cardiovasc Surg       Date:  1975-09       Impact factor: 5.209

7.  Chemotherapy as an adjuvant to surgery for colorectal cancer. A follow-up report.

Authors:  W Lawrence; J J Terz; J S Horsley; P W Brown; C Romero
Journal:  Arch Surg       Date:  1978-02

8.  Improvement in the results of treatment of osteogenic sarcoma.

Authors:  H O Douglass; J Wang; H Takita; H J Wallace; M Friedman; E Mindell
Journal:  Surg Gynecol Obstet       Date:  1975-05

9.  Bone-marrow transplantation in acute leukaemia.

Authors:  R P Gale; S Feig; W G Ho; P Falk; D Winston; L S Young; G Opelz; G Opelz; A Tesler; R Sparkes; P R Graze; G Sarna; D W Golde; M C Territo; Y Bryson; T Gossett; F Naiem; F Fawzy; C Haskell; J L Fahey; M J Cline
Journal:  Lancet       Date:  1977-12-10       Impact factor: 79.321

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.